Outsourced Pharma Services: The Pulse of M&A

GettyImages-1499814869

This article discusses the latest trends impacting outsourced pharma services M&A and market sentiment of CEOs and shareholders in the space.

Outsourced Pharma Services: 2024 M&A Trends & Outlook

Harris-Williams Bio-Crop 0040 JulianFeneley 1

Managing Director

Profile

Harris-Williams Bio-Crop 0021 089 DanLinsalata

Harris-Williams Bio-Crop 0003 AndreyDvorkin

Director

IntegriChain Acquired by Nordic Capital   

5991 IntegriChain NT

Mergers & Acquisitions

Harris Williams advised Alliance Animal Health, a portfolio company of LightBay Capital, on its sale to L Catterton. Alliance Animal Health is a leading platform of general and emergency hospitals across the United States with a unique JV partnership model.

Alliance Animal Health

United States

5482_alliance_animal_health.png

Pharmalex

Germany

5543 Pharmalex (Project I) NT

Celerion

5516 Celerion NT

The CM Group

5679 The CM Group

Harris Williams advised Jordi Labs on its sale to RQM+, a portfolio company of Linden Capital Partners. Jordi Labs is a leader in analytical chemistry testing, delivering a full suite of regulatory, investigative, and related services to the medical device, pharmaceutical, and other industries.

Jordi Labs

5663 Jordi Labs NT

An analytics-driven commercialization solutions provider for biopharmaceutical customers 
 
 A portfolio company of Windrose Health Investors 
 
 Has been recapitalized by Court Square Capital Partners

Medical Knowledge Group

medical-knowledge-group-2.png

Harris Williams advised Transaction Data Systems (TDS), a portfolio company of GTCR, on its sale to BlackRock Long Term Private Capital. TDS is a leader in pharmacy software solutions and services.

Transaction Data Systems

transaction-data-systems.png

Site Map

Privacy

Terms Of Use

Cookie Policy

Disclosures

We are a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality.

About Us

Our Capabilities

We have eight dedicated Industry Groups led by senior professionals who have deep knowledge and experience across sectors, service offerings, and geographies.

Our Industries

Access our latest insights on evolving industry dynamics and marketplace trends.

Our Insights

Our momentum as a firm is strong. We carry this momentum forward by hiring people who are smart, driven, and principled. If you are a team player who thrives on collaborating with colleagues and clients, we invite you to learn more about our career opportunities. 

Select Activity

Healthcare & Life Sciences

Outsourced Pharma Services & Pharma Technology Q4 2023

Outsourced Pharma Services: Three CEOs Talk Trends and M&A

Return on Innovation: An Eight-Part Series

Select Activity

Related Insights

Healthcare & Life Sciences

Outsourced Pharma Services & Pharma Technology Q4 2023

Outsourced Pharma Services: Three CEOs Talk Trends and M&A

Return on Innovation: An Eight-Part Series